Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors

被引：1

作者：

Alcazer, Vincent ^{[1
,2
]}

de Latour, Regis Peffault ^{[3
,4
]}

Ader, Florence ^{[5
,6
]}

Labussiere-Wallet, Helene ^{[1
]}

机构：

[1] Hosp Civils Lyon, Dept Hematol Clin, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France

[2] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS 5286, F-69008 Lyon, France

[3] Hop St Louis, AP HP, Serv Hematol Greffe, F-75006 Paris, France

[4] Univ Paris Diderot, F-75007 Paris, France

[5] Hosp Civils Lyon, Serv Malad Infect, F-69004 Lyon, France

[6] Ctr Int Rech Infectiol, Inserm U1111, CNRS 5308, F-69008 Lyon, France

来源：

BULLETIN DU CANCER | 2019年 / 106卷 / 06期

关键词：

Allogeneic hematopoietic; stem cell transplantation; Graft failure; Rejection; Infections; ANTI-HLA ANTIBODIES; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; RETROSPECTIVE ANALYSIS; FRANCOPHONE SOCIETY; APLASTIC-ANEMIA; DONOR; IMPACT; OUTCOMES; ENGRAFTMENT;

D O I：

10.1016/j.bulcan.2019.03.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained engraftment of the donor stem cells is essential for transplant success and overall outcome. Graft failure is a rare but severe event after allogeneic hematopoietic stem cell transplantation. While different risk factors such as underlying disease, graft source or HLA matching have been found to be consistently associated with graft failure, other factors such as ABO mismatch graft-versus-host disease prophylaxis or infections, particularly viral reactivations, are more controversial. In this article, we review the different factors associated with graft failure.

引用

页码：574 / 583

页数：10

共 58 条

[1] Effects of spleen status on early outcomes after hematopoietic cell transplantation [J].

Akpek, G. ;

Pasquini, M. C. ;

Logan, B. ;

Agovi, M-A ;

Lazarus, H. M. ;

Marks, D. I. ;

Bornhaeueser, M. ;

Ringden, O. ;

Maziarz, R. T. ;

Gupta, V. ;

Popat, U. ;

Maharaj, D. ;

Bolwell, B. J. ;

Rizzo, J. D. ;

Ballen, K. K. ;

Cooke, K. R. ;

McCarthy, P. L. ;

Ho, V. T. .

BONE MARROW TRANSPLANTATION, 2013, 48 (06) :825-831

[2] Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease [J].

Al-Homsi, Ahmad Samer ;

Roy, Tara S. ;

Cole, Kelli ;

Feng, Yuxin ;

Duffner, Ulrich .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) :604-611

[3] EFFECT OF HLA COMPATIBILITY ON ENGRAFTMENT OF BONE-MARROW TRANSPLANTS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA [J].

ANASETTI, C ;

AMOS, D ;

BEATTY, PG ;

APPELBAUM, FR ;

BENSINGER, W ;

BUCKNER, CD ;

CLIFT, R ;

DONEY, K ;

MARTIN, PJ ;

MICKELSON, E ;

NISPEROS, B ;

OQUIGLEY, J ;

RAMBERG, R ;

SANDERS, JE ;

STEWART, P ;

STORB, R ;

SULLIVAN, KM ;

WITHERSPOON, RP ;

THOMAS, ED ;

HANSEN, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :197-204

[4] ATG in allogeneic stem cell transplantation: standard of care in 2017? Point [J].

Bacigalupo, Andrea .

BLOOD ADVANCES, 2017, 1 (09) :569-572

[5] Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups [J].

Bacigalupo, Andrea ;

Socie, Gerard ;

Schrezenmeier, Hubert ;

Tichelli, Andre ;

Locasciulli, Anna ;

Fuehrer, Monika ;

Risitano, Antonio M. ;

Dufour, Carlo ;

Passweg, Jakob R. ;

Oneto, Rosi ;

Aljurf, Mahmoud ;

Flynn, Catherine ;

Mialou, Valerie ;

Hamladji, Rose Marie ;

Marsh, Judith C. W. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1142-1148

[6] Anti-HLA Antibodies in Double Umbilical Cord Blood Transplantation [J].

Brunstein, Claudio G. ;

Noreen, Harriet ;

DeFor, Todd E. ;

Maurer, David ;

Miller, Jeffrey S. ;

Wagner, John E. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) :1704-1708

[7] Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the severe aplastic anaemia working party of the European society for blood and marrow transplantation [J].

Cesaro, Simone ;

de latour, Regis Peffault ;

Tridello, Gloria ;

Pillon, Marta ;

Carlson, Kristina ;

Fagioli, Franca ;

Jouet, Jean-Pierre ;

Koh, Mickey B. C. ;

Panizzolo, Irene Sara ;

Kyrcz-Krzemien, Slawomira ;

Maertens, Johan ;

Rambaldi, Alessandro ;

Strahm, Brigitte ;

Blaise, Didier ;

Maschan, Alexei ;

Marsh, Judith ;

Dufour, Carlo .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) :606-614

[8] The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation [J].

Ciurea, Stefan O. ;

Cao, Kai ;

Fernadez-Vina, Marcelo ;

Kongtim, Piyanuch ;

Al Malki, Monzr ;

Fuchs, Ephraim ;

Luznik, Leo ;

Huang, Xiao-Jun ;

Ciceri, Fabio ;

Locatelli, Franco ;

Aversa, Franco ;

Castagna, Luca ;

Bacigalupo, Andrea ;

Martelli, Massimo ;

Blaise, Didier ;

Handgretinger, Rupert ;

Roy, Denis-Claude ;

O'Donnell, Paul ;

Bashey, Asad ;

Lazarus, Hillard M. ;

Ballen, Karen ;

Savani, Bipin N. ;

Mohty, Mohamad ;

Nagler, Arnon .

BONE MARROW TRANSPLANTATION, 2018, 53 (05) :521-534

[9] Donor-specific anti-HLAAbs and graft failure in matched unrelated donor hematopoietic stem cell transplantation [J].

Ciurea, Stefan O. ;

Thall, Peter F. ;

Wang, Xuemei ;

Wang, Sa A. ;

Hu, Ying ;

Cano, Pedro ;

Aung, Fleur ;

Rondon, Gabriela ;

Molldrem, Jeffrey J. ;

Korbling, Martin ;

Shpall, Elizabeth J. ;

de Lima, Marcos ;

Champlin, Richard E. ;

Fernandez-Vina, Marcelo .

BLOOD, 2011, 118 (22) :5957-5964

[10] Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI [J].

Cluzeau, T. ;

Lambert, J. ;

Raus, N. ;

Dessaux, K. ;

Absi, L. ;

Delbos, F. ;

Devys, A. ;

De Matteis, M. ;

Dubois, V. ;

Filloux, M. ;

Fort, M. ;

Hau, F. ;

Jollet, I. ;

Labalette, M. ;

Masson, D. ;

Mercier, B. ;

Pedron, B. ;

Perrier, P. ;

Picard, C. ;

Quainon, F. ;

Ramounau-Pigot, A. ;

Renac, V. ;

Van Endert, P. ;

Charron, D. ;

de la Tour, R. Peffault ;

Taupin, J. L. ;

Loiseau, P. .

BONE MARROW TRANSPLANTATION, 2016, 51 (05) :687-691

← 1 2 3 4 5 6 →